Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data ...
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...
The annual "Plunging for Pink" event returns to Austin's East Side Lake on Saturday, January 31st. It's part of the "Paint the Town Pink" campaign.
A restaurant owner has raised more than $150,000 for families facing breast cancer by asking customers to round up their bills.
New study by UC Santa Cruz team discovers that early pregnancy in mice reduces buildup of ‘confused’ cells that could lead to breast cancer later in life ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
5 Popular Frozen Pizzas Are Under Scrutiny for Possible Cancer Risks ...
When Kat Denisi was diagnosed she said she was completely unprepared for one life-altering side effect.
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
Gloria Vasquez, 74, is four races away from accomplishing her personal goal of completing 100 marathons. On Sunday, Feb. 1, 2026, she will run her 97th race at the DONNA Marathon in Jacksonville. The ...
HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
The screenings revealed she had breast cancer. Despite the terrifying diagnosis, she received high-quality care, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results